Five-day course of Molnupiravir effective and safe for non-pregnant and unvaccinated COVID-19 adult patients: Study Read more
SMS Pharmaceuticals receives non-exclusive licence to manufacture and supply Molnupiravir through MPP Read more
Fermenta Biotech licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharma Read more